Receptor activator of nuclear factor-κB ligand in T cells and dendritic cells communication

Hyun-Ja Jeong (정현자); Sun-Young Nam

Receptor activator of nuclear factor-κB ligand in T cells and dendritic cells communication

CELLMED
Abbr : CellMed
2013, 3(1), pp.3-3
Publisher : Cellmed Orthocellular Medicine and Pharmaceutical Association
Research Area : Medicine and Pharmacy > General Medicine

¹호서대학교
²Kyung Hee University

ABSTRACT

The receptor activator of NF-κB ligand (RANKL), a member of the tumor necrosis factor ligand family, has extensive functions beyond osteoclast development. RANKL is expressed in many immune cells such as osteoblasts, osteocytes, marrow stromal cells, activated T cells, synovial cells, keratinocytes, and mammary gland epithelial cells as well as in various tissues. The ligation of RANK by RANKL promotes dendritic cells (DCs) survival through prosurvival signals and the up-regulation of the anti-apoptotic proteins Bcl-2 and Bcl-xL and plays a crucial role in DCs-mediated Th1 differentiation. Therefore, RANKL plays an important role in the regulation of DCs/T cells-mediated specific immunity. This review will briefly inform our current understanding of the role of RANKL signaling in T cells-DCs communication in the immune system.

KEYWORDS

RANKL, dendritic cells, T cells, differentiation, immunity

Citation status

* References for papers published after 2023 are currently being built.

[journal] Akiyama T / 2012 / RANKL-RANK interaction in immune regulatory systems / World J ORthop 3 : 142~150

[journal] Anderson DM / 1997 / A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function / Nature 390 : 175~179

[journal] Boyce BF / 2007 / Biology of RANK, RANKL, and osteoprotegrin / Arthritis Res Ther 9 : S1~

[journal] Burger EH / 1984 / Osteoclast formation from mononuclear phagocytes: role of bone -forming cells / J Cell Biol 99 : 1901~1906

[journal] Caux C / 1994 / Activation of human dendritic cells through CD40 cross-linking / J Exp Med 184 : 1263~1272

[journal] Chan FK / 2000 / A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling / Science 288 : 2351~2354

[journal] Ikedda T / 2001 / Determination of three isoforms of the receptor activator of nuclear factor-kB ligand and their differential expression in bone and thymus / Endocrinology 142 : 1419~1426

[journal] Ito S / 2002 / Crytal structure of the extracellular domain of mouse RANK ligand at 2.2Å- resolution / J Biol Chem 277 : 6631~6636

[journal] Josien R / 1999 / TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells / J Immunol 162 : 2562~2568

[journal] Kartsoginannis V / 1999 / Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeleta tissues / Bone 25 : 525~534

[journal] Kong YY / 1999 / Activated T cell regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand / Nature 402 : 304~313

[journal] Lacey DL / 1998 / Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation / Cell 93 : 165~176

[journal] Lam J / 2001 / Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptor-ligand specificity / J Clin Invest 108 : 971~979

[journal] Leibbrandt A / 2008 / RANK/RANKL: Regulators of Immune responses and bone physiology / Ann N Y Acad Sci 1143 : 123~150

[journal] Loser K / 2006 / Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells / Nat Med 12 : 1372~1379

[journal] Lum L / 1999 / Evidence for a role of a tumor necrosis factor-a(TNF-a)-converting Enzyme-like protease in shedding of TRANCE, a TNf family member Involved in osteoclastogenesis and dendritic cell survival / J Biol Chem 274 : 13613~13618

[journal] Nakashima T / 2000 / Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kB ligand: modulation of the expression by osteotropic factors and cytokines / Biochem Biophys Res Commun 275 : 768~775

[journal] Rodan GA / 1981 / Role of osteoblasts in hormonal control of bone resorption: a hypothesis / Calcif Tissue Int 33 : 349~351

[journal] Schett G / 2005 / Mechanisms of disease: the link between RANKL and arthritic bone disease / Nat Clin Pract Rheumatol 1 : 47~54

[journal] Tsuda E / 1997 / Isolation of a novel cytokine from huma fibrobalsts that specifically inhibits osteoclastogenesis / Biochem Biophys Res Commun : 137~142

[journal] Wada T / 2006 / RANKL-RANK signaling in osteoclastogenesis and bone disease / Trends Mol Med 12 : 17~25

[journal] Wong BR / 1997 / TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells / J Biol Chem 272 : 25190~25194

[journal] Wong BR / 1997 / TRANCE (tumor necrosis factor –related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor / J Exp Med 186 : 2075~2080

[journal] Wong BR / 1997 / TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal KInase in T cells / J Biol Chem 272 : 25190~25194

[journal] Wong BR / 1998 / The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor / J Biol Chem 273 : 28355~28359

[journal] Yasuda H / 1998 / Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL / Proc Natl Acad Sci USA 95 : 3597~3602

KJCKorea
Journal Central

CELLMED 2023 KCI Impact Factor : 0.03